Valuation: DexCom, Inc.

Market Cap 27.2B 23.92B 22.22B 20.44B 38.33B 2,634B 39.01B 266B 104B 1,285B 102B 99.89B 4,457B P/E 2026 *
28.8x
P/E 2027 * 24.1x
Enterprise Value 26.77B 23.54B 21.87B 20.11B 37.72B 2,592B 38.4B 262B 102B 1,264B 100B 98.32B 4,386B EV / Sales 2026 *
5.12x
EV / Sales 2027 * 4.45x
Free-Float
93.35%
Yield 2026 *
-
Yield 2027 * -
1 day+0.81%
1 week-7.78%
Current month+4.05%
1 month+0.33%
3 months+17.56%
6 months-0.29%
Current year+8.03%
1 week 61.6
Extreme 61.6
67.2
1 month 58.6
Extreme 58.6
68.4
Current year 48.5
Extreme 48.5
68.4
1 year 46.88
Extreme 46.88
77.17
3 years 46.88
Extreme 46.88
131.88
5 years 46.88
Extreme 46.88
144.55
10 years 9.12
Extreme 9.125
144.55
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%-7.78% - - 27.2B
+2.81%+2.60%-17.78%-9.88% 175B
+1.59%+0.02%-9.86%-6.25% 105B
+1.39%+0.32%+6.35%+61.34% 59.35B
-1.13%-1.96%+32.11%+56.38% 50.71B
+1.58%-1.64%-15.28%-44.43% 42.15B
+4.17%-1.83% - - 31.82B
-3.98%-4.76%+22.25%-9.27% 25.11B
+1.85%-1.65%-5.72%-7.72% 20.53B
+0.30%-1.93%-12.56%-1.07% 19.42B
Average +0.95%-2.60%-0.06%+4.89% 58.84B
Weighted average by Cap. +1.54%-1.12%-5.22%+3.67%

Financials

2026 *2027 *
Net sales 5.22B 4.59B 4.27B 3.93B 7.36B 506B 7.49B 51.04B 19.91B 247B 19.61B 19.19B 856B 5.83B 5.12B 4.76B 4.38B 8.21B 564B 8.36B 56.93B 22.2B 275B 21.87B 21.4B 955B
Net income 959M 844M 784M 721M 1.35B 92.92B 1.38B 9.37B 3.66B 45.32B 3.6B 3.52B 157B 1.16B 1.02B 946M 870M 1.63B 112B 1.66B 11.31B 4.41B 54.67B 4.34B 4.25B 190B
Net Debt -429M -377M -350M -322M -604M -41.52B -615M -4.19B -1.63B -20.25B -1.61B -1.57B -70.25B -1.28B -1.13B -1.05B -962M -1.8B -124B -1.84B -12.51B -4.88B -60.49B -4.81B -4.7B -210B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-07-24 61.60 -0.32% 67
26-07-23 €61.80 -1.59% 236
26-07-22 €62.80 -4.27% 20
26-07-21 €65.60 -2.09% 0
26-07-20 €67.00 +0.30% 125
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
70.48USD
Average target price
85.75USD
Spread / Average Target
+21.67%

Quarterly revenue - Rate of surprise